These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6788371)

  • 1. Double alkylator therapy (thiotepa plus chlorambucil) for previously treated advanced ovarian cancer.
    Ozols RF; Howser DM; Young RC
    Cancer Treat Rep; 1981; 65(7-8):731. PubMed ID: 6788371
    [No Abstract]   [Full Text] [Related]  

  • 2. High dose thiotepa in ovarian cancer.
    Shetty PA; Kurkure PA; Pai VR; Gohokar D; Pai S; Shinde SR; D'Souza LJ; Sampat MB
    Indian J Cancer; 1985 Mar; 22(1):33-7. PubMed ID: 3939232
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in erythropoiesis in patients with malignant tumors of the ovaries during chemotherapy].
    Bruk AA; Loskutova GP; Turbina IL
    Vopr Onkol; 1967; 13(12):21-3. PubMed ID: 4970401
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of ovarian cancer with thiotepa.
    Kottmeier HL
    Clin Obstet Gynecol; 1968 Jun; 11(2):428-38. PubMed ID: 4176467
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotherapy-associated acute myelogenous leukemia and ovarian carcinoma.
    Haque T; Lutcher C; Faguet G; Talledo O
    Am J Med Sci; 1976; 272(2):225-8. PubMed ID: 827211
    [No Abstract]   [Full Text] [Related]  

  • 6. A phase II study of intraperitoneal cisplatin and thiotepa in residual ovarian carcinoma: a Gynecologic Oncology Group study.
    Feun LG; Blessing JA; Major FJ; DiSaia PJ; Alvarez RD; Berek JS
    Gynecol Oncol; 1998 Dec; 71(3):410-5. PubMed ID: 9887240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ways of reducing the toxicity of chemotherapy of cancer of the ovaries].
    Shuvaeva NI; Novikova EG; Vedernikova NV; Antoshechkina ET
    Sov Med; 1986; (5):24-8. PubMed ID: 3088736
    [No Abstract]   [Full Text] [Related]  

  • 8. Single-drug therapy in ovarian cancer.
    Hreshchyshyn MM
    Obstet Gynecol Surv; 1974 Jul; 29():497-9. PubMed ID: 4217889
    [No Abstract]   [Full Text] [Related]  

  • 9. [A phase II study of prednimustine in advanced ovarian cancer].
    Grundsell H; Johnsson JE; Tropé C
    Lakartidningen; 1980 Sep; 77(39):3394-7. PubMed ID: 6161283
    [No Abstract]   [Full Text] [Related]  

  • 10. Thiotepa, cutaneous reactions, and efficacy.
    Greenspan EM; Jaffrey I; Bruckner H
    JAMA; 1977 May; 237(21):2288. PubMed ID: 404440
    [No Abstract]   [Full Text] [Related]  

  • 11. Chlorambucil for platinum-refractory ovarian cancer.
    Taylor AE; Gore ME
    Clin Oncol (R Coll Radiol); 1994; 6(3):177-8. PubMed ID: 8086353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Palliative treatment of ovarian cancers with the association of thiotepa and of 5-fluoro-uracil].
    Simon G; Brunet R; Chauvergne J
    Bord Med; 1971 May; 4(5):1523-30. PubMed ID: 4105607
    [No Abstract]   [Full Text] [Related]  

  • 13. Reversible central nervous system toxicity associated with high-dose chlorambucil in autologous bone marrow transplantation for ovarian carcinoma.
    Ciobanu N; Runowicz C; Gucalp R; Frank M; Charuvanki V; Kaufman D; Wiernik PH
    Cancer Treat Rep; 1987 Dec; 71(12):1324-5. PubMed ID: 3319137
    [No Abstract]   [Full Text] [Related]  

  • 14. [Malignant tumor of the ovary and Thiotepa: an original route of administration].
    Wolff JP; Toudoire A
    Bull Fed Soc Gynecol Obstet Lang Fr; 1966; 18(2):131-4. PubMed ID: 4958485
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chemotherapy in ovarian cancer].
    Nyström C
    Nord Med; 1970 Dec; 84(50):1601. PubMed ID: 4997057
    [No Abstract]   [Full Text] [Related]  

  • 16. [Intrastitial chemotherapy of disseminated ovarian cancer].
    Blok MIa
    Vopr Onkol; 1985; 31(3):101-3. PubMed ID: 3922115
    [No Abstract]   [Full Text] [Related]  

  • 17. High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancer.
    Holmberg LA; Demirer T; Rowley S; Buckner CD; Goodman G; Maziarz R; Klarnet J; Zuckerman N; Harrer G; McCloskey R; Gersh R; Goldberg R; Nichols W; Jacobs A; Weiden P; Montgomery P; Rivkin S; Appelbaum FR; Bensinger WI
    Bone Marrow Transplant; 1998 Oct; 22(7):651-9. PubMed ID: 9818692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged intake of chlorambucil for ovarian cancer.
    Khalil AM; Khatib RA; Shamseddine AI; Sharara NH; Seoud MA
    Eur J Obstet Gynecol Reprod Biol; 1995 May; 60(1):85-6. PubMed ID: 7635238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carboplatin versus cisplatin in ovarian cancer.
    Alberts DS
    Semin Oncol; 1995 Oct; 22(5 Suppl 12):88-90. PubMed ID: 7481869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biweekly chlorambucil treatment of lymphocytic lymphoma.
    Knospe WH; Loeb V
    Cancer Clin Trials; 1980; 3(4):329-36. PubMed ID: 7428139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.